112.30 0.25 (0.22%)
NSEJan 27, 2021 03:54 PM
Latest broker research reports with buy, sell, hold recommendations along with forecast target prices and upside. Browse thousands of reports and search by company or the broker.
|Summary||Date||Stock||Broker||Price at Reco.||Target||Price at reco|
Change since reco(%)
|2015-07-09||SMS Pharmaceuticals .. +||Karvy||60.88||60.88 (84.46%)||Pre-Bonus/|
Scaled up base portfolio: The company has a base portfolio in long standingGastrointestinal and Antimigraine accounting for close to 40% of existing portfolio.Operating in such long standing therapies, the company delivered Rs. 5000 Mn inrevenues in FY14 (111% YoY) and sustained the scale with 12% growth in FY15.